{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T05:36:47Z","timestamp":1741066607808,"version":"3.38.0"},"reference-count":36,"publisher":"European Respiratory Society (ERS)","issue":"2","license":[{"start":{"date-parts":[[2024,10,10]],"date-time":"2024-10-10T00:00:00Z","timestamp":1728518400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["publications.ersnet.org"],"crossmark-restriction":true},"short-container-title":["ERJ Open Res"],"accepted":{"date-parts":[[2024,9,10]]},"published-print":{"date-parts":[[2025,3]]},"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>In Spain, notifications of cases of tuberculosis (TB) are registered through the National Epidemiological Surveillance Network (RENAVE). The Minimum Basic Data Set (CMBD) provides information on hospital discharge and the National Statistics Institute (INE) draws on medical death certificates. This study aimed to describe TB mortality in Spain and to compare estimates across data sources, as well as with EU\/EEA countries.<\/jats:p><\/jats:sec><jats:sec><jats:title>Material and methods<\/jats:title><jats:p>A retrospective study of TB data between 2008 and 2021 was performed. Mortality rates (MRs) were calculated for the three databases as well as case fatality rates (CFRs) for TB location and HIV status using RENAVE data. Time trends were calculated and the mean MR and annual mean percentage change for Spain were compared with EU\/EEA countries.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Between 2008 and 2021, 4127 TB deaths were reported to RENAVE, 3877 to INE and 4775 to CMBD. The MR was 0.62 per 100\u2009000 inhabitants for RENAVE, 0.59 for INE and 0.72 for CMBD. A statistically significant downward annual trend was observed. Highest MRs across all databases were found in men and in those over 80\u2005years old. CFR was higher for meningeal TB and for HIV patients with a risk ratio of 2.02 (95% CI 1.82\u20132.2; p&lt;0.05).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Although the TB MR in Spain has followed a downward annual trend, it is necessary to continue improving prevention, diagnosis and treatment. This will require comprehensive measurement, better knowledge and better use of all information to complement surveillance systems.<\/jats:p><\/jats:sec>","DOI":"10.1183\/23120541.00636-2024","type":"journal-article","created":{"date-parts":[[2024,10,10]],"date-time":"2024-10-10T11:15:13Z","timestamp":1728558913000},"page":"00636-2024","update-policy":"https:\/\/doi.org\/10.1183\/ers-crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Estimation of tuberculosis mortality burden in Spain: a review of the major data sources"],"prefix":"10.1183","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0988-9590","authenticated-orcid":false,"given":"Miriam","family":"Roncal Redin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diana","family":"G\u00f3mez Barroso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Herrera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javier","family":"G\u00f3mez-Castell\u00e1","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zaida","family":"Herrador","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"the Spanish Working Group on Tuberculosis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"81","published-online":{"date-parts":[[2024,10,10]]},"reference":[{"key":"2025030303500908000_11.2.00636-2024.1","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1093\/ije\/dyy144","article-title":"What is the true tuberculosis mortality burden? Differences in estimates by the World Health Organization and the Global Burden of Disease study","volume":"47","author":"Garc\u00eda-Basteiro","year":"2018","journal-title":"Int J Epidemiol"},{"key":"2025030303500908000_11.2.00636-2024.2","unstructured":"World Health Organization. Tuberculosis. Date last accessed: 26 January 2024. www.who.int\/es\/news-room\/fact-sheets\/detail\/tuberculosis"},{"key":"2025030303500908000_11.2.00636-2024.3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.26633\/RPSP.2019.102","article-title":"Factores asociados a la mortalidad por tuberculosis en Paraguay, 2015-2016","volume":"43","author":"Medina","year":"2019","journal-title":"Rev Panam Salud P\u00fablica"},{"key":"2025030303500908000_11.2.00636-2024.4","unstructured":"World Health Organization. Global Tuberculosis Report 2023. Date last accessed: 6 February 2024. Date last updated: 7 November 2023. https:\/\/www.who.int\/publications\/i\/item\/9789240083851"},{"key":"2025030303500908000_11.2.00636-2024.5","unstructured":"European Centre for Disease Prevention and Control. Tuberculosis surveillance and monitoring in Europe 2022\u20132020 data. Publications Office of the European Union, 2022. Date last accessed: 5 March 2024. https:\/\/data.europa.eu\/doi\/10.2900\/488579"},{"key":"2025030303500908000_11.2.00636-2024.6","unstructured":"Centro Nacional de Epidemiolog\u00eda. Instituto de Salud Carlos III. Red Nacional de Vigilancia Epidemiol\u00f3gica (RENAVE). Resultados de la vigilancia de la tuberculosis. 2023. Date last accessed: 20 February 2024. www.isciii.es\/QueHacemos\/Servicios\/VigilanciaSaludPublicaRENAVE\/EnfermedadesTransmisibles\/Documents\/archivos%20A-Z\/Tuberculosis\/RENAVE_informe_Vigilancia%20TB_%202022.pdf"},{"key":"2025030303500908000_11.2.00636-2024.7","unstructured":"World Health Organization. The End TB strategy. 2015. Date last accessed: 6 February 2024. www.who.int\/publications-detail-redirect\/WHO-HTM-TB-2015.19"},{"key":"2025030303500908000_11.2.00636-2024.8","unstructured":"Grupo de trabajo Plan Prevenci\u00f3n y Control de la Tuberculosis. Plan para la prevenci\u00f3n y control de la tuberculosis en Espa\u00f1a. Comisi\u00f3n de Salud P\u00fablica del Consejo Interterritorial del Sistema Nacional de Salud. Ministerio de Sanidad, Consumo y Bienestar Social, marzo 2019. Date last accessed: 9 January 2024. www.sanidad.gob.es\/profesionales\/saludPublica\/prevPromocion\/PlanTuberculosis\/docs\/Resumen_PlanTB2019.pdf"},{"key":"2025030303500908000_11.2.00636-2024.9","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.eimc.2017.11.013","article-title":"Epidemiology of tuberculosis in Spain. Results obtained by the National Epidemiological Surveillance Network in 2015","volume":"36","author":"Cano-Portero","year":"2018","journal-title":"Enfermedades Infecc Microbiol Clin Engl Ed"},{"key":"2025030303500908000_11.2.00636-2024.10","doi-asserted-by":"crossref","first-page":"e0295918","DOI":"10.1371\/journal.pone.0295918","article-title":"The epidemiological situation of tuberculosis in Spain according to surveillance and hospitalization data, 2012\u20132020.","volume":"19","author":"Pedraz","year":"2024","journal-title":"PLoS One"},{"key":"2025030303500908000_11.2.00636-2024.11","unstructured":"Ministry of Health and Consumer Affairs. General provisions. BOE-A-1996-1502. www.boe.es\/eli\/es\/rd\/1995\/12\/28\/2210 ."},{"key":"2025030303500908000_11.2.00636-2024.12","unstructured":"Centro Nacional de Epidemiolog\u00eda. Protocolo de Vigilancia de Tuberculosis . 2013. Date last accessed: 8 February 2024. https:\/\/cne.isciii.es\/documents\/d\/cne\/protocolo-20de-20vigilancia-20de-20tuberculosis-pdf."},{"key":"2025030303500908000_11.2.00636-2024.13","unstructured":"Commission Implementing Decision (EU) 2018\/945 of 22 June 2018 on the communicable diseases and related special health issues to be covered by epidemiological surveillance as well as relevant case definitions (text with EEA relevance). https:\/\/eur-lex.europa.eu\/eli\/dec_impl\/2018\/945\/oj"},{"key":"2025030303500908000_11.2.00636-2024.14","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s00414-021-02733-6","article-title":"Judicial consequences in Spain for the completion of the medical death certificate","volume":"136","author":"Pinto Pastor","year":"2022","journal-title":"Int J Legal Med"},{"key":"2025030303500908000_11.2.00636-2024.15","unstructured":"Ministry of Health. Registro de Actividad de Atenci\u00f3n Sanitaria Especializada (RAE-CMBD): Actividad y resultados de la hospitalizaci\u00f3n en el SNS. A\u00f1o 2019. Madrid; 2021. https:\/\/www.sanidad.gob.es\/estadEstudios\/estadisticas\/sisInfSanSNS\/tablasEstadisticas\/InfAnSNSAnosanteriores.htm"},{"key":"2025030303500908000_11.2.00636-2024.16","unstructured":"Consulta Interactiva del SNS. Date last accessed: 22 March 2024. https:\/\/pestadistico.inteligenciadegestion.sanidad.gob.es\/publicoSNS\/N\/rae-cmbd\/rae-cmbd\/diagnosticos-principales"},{"key":"2025030303500908000_11.2.00636-2024.17","unstructured":"European Centre for Disease Prevention and Control. Annual Epidemiological Reports (AERs). Date last accessed: 2 April 2024. www.ecdc.europa.eu\/en\/publications-data\/monitoring\/all-annual-epidemiological-reports"},{"key":"2025030303500908000_11.2.00636-2024.18","unstructured":"National Cancer Institute. Joinpoint Regression Program. Date last accessed: 15 March 2024. https:\/\/surveillance.cancer.gov\/joinpoint\/"},{"key":"2025030303500908000_11.2.00636-2024.19","doi-asserted-by":"crossref","first-page":"281","DOI":"10.15585\/mmwr.mm6911a2","article-title":"Global epidemiology of tuberculosis and progress toward meeting global targets: worldwide, 2018","volume":"69","author":"MacNeil","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2025030303500908000_11.2.00636-2024.20","doi-asserted-by":"publisher","DOI":"10.1043\/1543-2165(2005)129[1476:DCEAAA]2.0.CO;2"},{"key":"2025030303500908000_11.2.00636-2024.21","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.eimc.2017.05.009","article-title":"Mortality trends for tuberculosis in European Union countries, 2000\u20132010","volume":"36","author":"Al-Rahamneh","year":"2018","journal-title":"Enfermedades Infecc Microbiol Cl\u00ednica"},{"key":"2025030303500908000_11.2.00636-2024.22","unstructured":"\u00c1rea de vigilancia del VIH y conductas de riesgo. Epidemiolog\u00eda del VIH y de otras Infecciones de Transmisi\u00f3n Sexual en mujeres. Espa\u00f1a, Diciembre 2018. Madrid: Centro Nacional de Epidemiolog\u00eda-Instituto de Salud Carlos III\/ Plan Nacional sobre el SidaDirecci\u00f3n General de Salud P\u00fablica, Calidad e Innovaci\u00f3n; 2018."},{"key":"2025030303500908000_11.2.00636-2024.23","first-page":"123","article-title":"Gender and tuberculosis: a comparison of prevalence surveys with notification data to explore sex differences in case detection","volume":"4","author":"Borgdorff","year":"2000","journal-title":"Int J Tuberc Lung Dis"},{"key":"2025030303500908000_11.2.00636-2024.24","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-61503-3"},{"key":"2025030303500908000_11.2.00636-2024.25","doi-asserted-by":"crossref","first-page":"e32811","DOI":"10.1097\/MD.0000000000032811","article-title":"Predictors of death among TB\/HIV co-infected patients on tuberculosis treatment in Sichuan, China: a retrospective cohort study","volume":"102","author":"Yang","year":"2023","journal-title":"Medicine (Baltimore)"},{"key":"2025030303500908000_11.2.00636-2024.26","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.annepidem.2012.04.010","article-title":"Mortality from tuberculosis in Spain, 1971 to 2007: slow decrease in female and in elderly patients","volume":"22","author":"Llorca","year":"2012","journal-title":"Ann Epidemiol"},{"key":"2025030303500908000_11.2.00636-2024.27","doi-asserted-by":"crossref","first-page":"107","DOI":"10.4321\/S0212-71992002000300001","article-title":"Tuberculosis en pacientes ancianos","volume":"19","author":"Salgueiro Rodr\u00edguez","year":"2002","journal-title":"An Med Interna (Madrid)"},{"key":"2025030303500908000_11.2.00636-2024.28","doi-asserted-by":"crossref","first-page":"3482","DOI":"10.1007\/s00415-022-11052-8","article-title":"Global morbidity and mortality of central nervous system tuberculosis: a systematic review and meta-analysis","volume":"269","author":"Navarro-Flores","year":"2022","journal-title":"J Neurol"},{"key":"2025030303500908000_11.2.00636-2024.29","first-page":"100377","article-title":"Epidemiology and factors associated with extra-pulmonary tuberculosis in a low-prevalence area","volume":"32","author":"Rolo","year":"2023","journal-title":"J Clin Tuberc Mycobact Dis"},{"key":"2025030303500908000_11.2.00636-2024.30","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1002464"},{"key":"2025030303500908000_11.2.00636-2024.31","first-page":"14","article-title":"WHO policy on collaborative TB\/HIV activities: guidelines for national programmes and other stakeholders","volume":"36","year":"2012","journal-title":"Polit OMS Pour Act Conjointes Lutte Contre Tuberc VIH Principes Dir \u00c0 Intent Programme Natx Autres Parten"},{"key":"2025030303500908000_11.2.00636-2024.32","doi-asserted-by":"crossref","first-page":"00730","DOI":"10.1183\/23120541.00730-2022","article-title":"Tuberculosis medicines for children in Europe: an unmet medical need","volume":"9","author":"Cherchi","year":"2023","journal-title":"ERJ Open Res"},{"key":"2025030303500908000_11.2.00636-2024.33","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/j.cmi.2020.12.006","article-title":"Extrapulmonary tuberculosis among migrants in Europe, 1995 to 2017","volume":"27","author":"Hayward","year":"2021","journal-title":"Clin Microbiol Infect"},{"key":"2025030303500908000_11.2.00636-2024.34","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2022.03.026"},{"key":"2025030303500908000_11.2.00636-2024.35","doi-asserted-by":"crossref","first-page":"102437","DOI":"10.1016\/j.aprim.2022.102437","article-title":"Evoluci\u00f3n de la prevalencia de arteriopat\u00eda perif\u00e9rica en la pr\u00e1ctica cl\u00ednica: Estudio descriptivo poblacional con bases de datos reales (SIDIAP-CMBD)","volume":"54","author":"For\u00e9s","year":"2022","journal-title":"Aten Primaria"},{"key":"2025030303500908000_11.2.00636-2024.36","doi-asserted-by":"crossref","first-page":"160","DOI":"10.37201\/req\/074.2022","article-title":"Validity and usefulness of the RAE-CMBD studying patients hospitalised with influenza","volume":"36","author":"Quir\u00f3s-Gonz\u00e1lez","year":"2023","journal-title":"Rev Esp Quimioter"}],"container-title":["ERJ Open Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1183\/23120541.00636-2024","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,3]],"date-time":"2025-03-03T11:51:11Z","timestamp":1741002671000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.ersnet.org\/lookup\/doi\/10.1183\/23120541.00636-2024"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,10]]},"references-count":36,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,3,3]]},"published-print":{"date-parts":[[2025,3]]}},"alternative-id":["10.1183\/23120541.00636-2024"],"URL":"https:\/\/doi.org\/10.1183\/23120541.00636-2024","relation":{},"ISSN":["2312-0541"],"issn-type":[{"type":"electronic","value":"2312-0541"}],"subject":[],"published":{"date-parts":[[2024,10,10]]}}}